On the relationship between the uncoupler-induced efflux of K+ from heart mitochondria and the oxidation-reduction state of pyridine nucleotides.
Respiring heart mitochondria exchange matrix 42K+ with extramitochondrial K+ at a rapid rate in the presence of Pi (Chávez, E., Jung, D. W., and Brierley, G. P. (1977) Arch. Biochem. Biophys. 183, 460-470, 1977). This exchange reaction is strongly inhibited by uncouplers. However, under two rather similar sets of conditions, the addition of an uncoupler results in a rapid, transient increase in the exchange of matrix 42K+ with external K+ when the mitochondria are suspended in KCl or, alternatively, in a net loss of matrix 42K+ from mitochondria suspended in K+-free media. These conditions are: (a) the addition of an uncoupler to respiring mitochondria after the accumulation of a small amount of phosphate salt, and (b) the presence of a Ca2+-chelator or ruthenium red with uncoupler. Loss of 42K+ under these conditions occurs with all substrates tested, is completely blocked by rotenone, and is accompanied by an almost complete oxidation of both NADH and NADPH. In the presence of rotenone and acetoacetate, only NADH is oxidized and 42K+ efflux does not occur. It is concluded that simply dissipating the mitochondrial protonmotive force by addition of an uncoupler is not sufficient to induce release of mitochondrial K+. Uncoupler-induced oxidation of mitochondrial NADPH, in conjunction with elevated internal Pi, opens a rather nonspecific pathway for K+ loss which can be inhibited by ADP and enhanced by Ca2+. The more specific loss of K+ which occurs in the absence of elevated internal Pi when uncoupler and EGTA or ruthenium red are present suggests that K+ efflux is related to the Ca2+-uniporter. Loss of K+ by either of these pathways can be differentiated from efflux of K+ on the endogenous K+/H+ exchanger which functions without dissipation of the mitochondrial membrane potential.
D000818:Animals; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone / Q000494:pharmacology; D002417:Cattle; D004533:Egtazic Acid / Q000494:pharmacology; D007700:Kinetics; D008929:Mitochondria, Heart / Q000187:drug effects / Q000378:metabolism*; D009243:NAD / Q000378:metabolism*; D009249:NADP / Q000378:metabolism*; D009840:Oligomycins / Q000494:pharmacology; D010084:Oxidation-Reduction; D011188:Potassium / Q000378:metabolism*; D012402:Rotenone / Q000494:pharmacology; D012430:Ruthenium Red / Q000494:pharmacology; D014475:Uncoupling Agents / Q000494:pharmacology*
D009840:Oligomycins; D014475:Uncoupling Agents; D012402:Rotenone; D009243:NAD; D012430:Ruthenium Red; D004533:Egtazic Acid; D009249:NADP; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone; D011188:Potassium